FI103510B1 - Menetelmä tekijän VIII eristämiseksi - Google Patents

Menetelmä tekijän VIII eristämiseksi

Info

Publication number
FI103510B1
FI103510B1 FI922105A FI922105A FI103510B1 FI 103510 B1 FI103510 B1 FI 103510B1 FI 922105 A FI922105 A FI 922105A FI 922105 A FI922105 A FI 922105A FI 103510 B1 FI103510 B1 FI 103510B1
Authority
FI
Finland
Prior art keywords
factor viii
isolating factor
isolating
proteins
plasma
Prior art date
Application number
FI922105A
Other languages
English (en)
Swedish (sv)
Other versions
FI922105A0 (fi
FI922105A (fi
FI103510B (fi
Inventor
Per Kaersgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI922105A0 publication Critical patent/FI922105A0/fi
Publication of FI922105A publication Critical patent/FI922105A/fi
Application granted granted Critical
Publication of FI103510B1 publication Critical patent/FI103510B1/fi
Publication of FI103510B publication Critical patent/FI103510B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Amplifiers (AREA)
  • Networks Using Active Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cephalosporin Compounds (AREA)
  • Housing For Livestock And Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI922105A 1989-11-09 1992-05-08 Menetelmä tekijän VIII eristämiseksi FI103510B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK562189 1989-11-09
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
DK9000279 1990-11-05
PCT/DK1990/000279 WO1991007438A1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii

Publications (4)

Publication Number Publication Date
FI922105A0 FI922105A0 (fi) 1992-05-08
FI922105A FI922105A (fi) 1992-05-08
FI103510B1 true FI103510B1 (fi) 1999-07-15
FI103510B FI103510B (fi) 1999-07-15

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922105A FI103510B (fi) 1989-11-09 1992-05-08 Menetelmä tekijän VIII eristämiseksi

Country Status (26)

Country Link
US (1) US5245014A (fi)
EP (1) EP0524172B1 (fi)
JP (1) JP2509407B2 (fi)
CN (1) CN1044121C (fi)
AT (1) ATE118508T1 (fi)
AU (1) AU631471B2 (fi)
BG (1) BG61231B1 (fi)
CA (1) CA2073012C (fi)
CZ (1) CZ537190A3 (fi)
DE (1) DE69017050T2 (fi)
DK (1) DK162233C (fi)
ES (1) ES2068404T3 (fi)
FI (1) FI103510B (fi)
HU (1) HU214905B (fi)
IE (1) IE66836B1 (fi)
IL (1) IL96277A (fi)
NO (1) NO180741C (fi)
NZ (1) NZ236004A (fi)
PL (1) PL164894B1 (fi)
PT (1) PT95830B (fi)
RU (1) RU2055593C1 (fi)
SK (1) SK278640B6 (fi)
UA (1) UA29421C2 (fi)
WO (1) WO1991007438A1 (fi)
YU (1) YU47524B (fi)
ZA (1) ZA908599B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0399321T3 (da) * 1989-05-24 1993-08-09 Miles Inc Gelfiltrering af varmebehandlet faktor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
MXPA01008515A (es) * 1999-02-22 2003-06-06 Baxter Int Formulaciones novedosas de factor viii libres de albumina.
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
PT1750733E (pt) 2004-05-03 2014-02-14 Baxter Healthcare Sa Método de administração de factor viii suíno sem domínio b
WO2006021584A2 (en) * 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
ES2706296T3 (es) * 2008-11-07 2019-03-28 Univ Connecticut Formulaciones de Factor VIII
ES2740825T3 (es) * 2010-03-30 2020-02-06 Octapharma Ag Un procedimiento de purificación de proteínas dependientes de vitamina K
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
EA035447B1 (ru) 2010-11-05 2020-06-17 Баксалта Инкорпорейтид Выделенный рекомбинантный вариант фактора viii (fviii) с частично удаленным в-доменом
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
JP6284481B2 (ja) * 2012-09-28 2018-02-28 中外製薬株式会社 血液凝固反応の評価方法
US9663553B2 (en) * 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
DE3851696T2 (de) * 1987-12-21 1995-02-23 Miles Inc Faktor VIII- Gelfiltration.
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
DK0399321T3 (da) * 1989-05-24 1993-08-09 Miles Inc Gelfiltrering af varmebehandlet faktor VIII

Also Published As

Publication number Publication date
DK162233C (da) 1992-03-16
DK162233B (da) 1991-09-30
RU2055593C1 (ru) 1996-03-10
IE66836B1 (en) 1996-02-07
DK562189A (da) 1991-05-10
UA29421C2 (uk) 2000-11-15
PT95830B (pt) 1997-11-28
NO921839L (no) 1992-07-08
IE904022A1 (en) 1991-05-22
SK537190A3 (en) 1997-12-10
IL96277A0 (en) 1991-08-16
DK562189D0 (da) 1989-11-09
AU6747090A (en) 1991-06-13
DE69017050T2 (de) 1995-06-14
YU210590A (sh) 1993-05-28
HU214905B (hu) 1998-07-28
CN1051732A (zh) 1991-05-29
PL164894B1 (pl) 1994-10-31
CZ537190A3 (cs) 1998-05-13
SK278640B6 (en) 1997-12-10
NZ236004A (en) 1991-11-26
JPH05501557A (ja) 1993-03-25
IL96277A (en) 1995-07-31
NO180741C (no) 1997-06-11
NO921839D0 (no) 1992-05-08
CA2073012C (en) 1996-03-19
EP0524172A1 (en) 1993-01-27
CA2073012A1 (en) 1991-05-10
ZA908599B (en) 1991-07-31
PL287703A1 (en) 1991-12-02
EP0524172B1 (en) 1995-02-15
HU9201551D0 (en) 1992-08-28
BG96316A (bg) 1993-12-24
DE69017050D1 (de) 1995-03-23
FI922105A0 (fi) 1992-05-08
FI922105A (fi) 1992-05-08
ES2068404T3 (es) 1995-04-16
BG61231B1 (en) 1997-03-31
ATE118508T1 (de) 1995-03-15
FI103510B (fi) 1999-07-15
AU631471B2 (en) 1992-11-26
CN1044121C (zh) 1999-07-14
HUT60511A (en) 1992-09-28
JP2509407B2 (ja) 1996-06-19
NO180741B (no) 1997-03-03
WO1991007438A1 (en) 1991-05-30
US5245014A (en) 1993-09-14
YU47524B (sh) 1995-10-03
PT95830A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
FI103510B1 (fi) Menetelmä tekijän VIII eristämiseksi
YU191387A (en) Process for extracting lipofilic proteins from host cells of pichia origin
DE58900776D1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
AU580494B2 (en) Process for the extraction and purification of proteins from culture media producing them
AU578554B2 (en) Centrifugal method of separating blood components
ES2168387T3 (es) Procedimiento de fraccionamiento de soluciones que contienen sacarosa.
NZ218913A (en) Process for separating components of natural gas
CY1105206T1 (el) Διαδικασια για την εκχυλιση και χρησιμοποιηση υγρου επωασης απο σολομο του ατλαντικου
AU5982490A (en) Membrane separation system and method of operation Case to be abandoned
KR880701778A (ko) 펩티드의 합성 및 분리를 위한 효소막법
GB1479512A (en) Dimeric indole alkaloid purification process
ES2049021T3 (es) Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion.
ATE66931T1 (de) Verfahren zur scheidung und isolierung von nosiheptid.
IT1135153B (it) Processo per rendere incoagulabile il sangue mediante enzimi proteolitici e uso del sangue incoagulabile per produrre un concentrato proteico da sangue intero
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
AU1885688A (en) Apparatus for separation of blood
DK690587A (da) Tetrapeptid, dets fremstilling og anvendelse
HK50691A (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
IL78130A (en) Method of separating or purifying proteins and other biopolymers
AU1929188A (en) Process for recovery of gold
BG44094A1 (en) Method for separating of furfurol from hydrolysate